CD15 anticorps (PE/Dazzle™ 594)
-
- Antigène Voir toutes CD15 (FUT4) Anticorps
- CD15 (FUT4) (Fucosyltransferase 4 (Alpha (1,3) Fucosyltransferase, Myeloid-Specific) (FUT4))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp CD15 est conjugé à/à la PE/Dazzle™ 594
-
Application
- Flow Cytometry (FACS)
- Purification
- The antibody was purified by affinity chromatography and conjugated with PE/Dazzle™ 594 under optimal conditions. The solution is free of unconjugated PE/Dazzle™ 594 and unconjugated antibody.
- Clone
- W6D3
- Isotype
- IgG1 kappa
- Top Product
- Discover our top product FUT4 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Protect from prolonged exposure to light. Do not freeze.
- Stock
- 4 °C
- Stockage commentaire
- The antibody solution should be stored undiluted between 2°C and 8°C.
-
- Antigène
- CD15 (FUT4) (Fucosyltransferase 4 (Alpha (1,3) Fucosyltransferase, Myeloid-Specific) (FUT4))
- Autre désignation
- CD15 (FUT4 Produits)
- Synonymes
- anticorps AI451562, anticorps CD15, anticorps FAL, anticorps FucT-IV, anticorps LeX, anticorps SSEA-1, anticorps Ssea1, anticorps ELFT, anticorps FCT3A, anticorps FUC-TIV, anticorps FUTIV, anticorps Fuct, anticorps fucosyltransferase 4, anticorps Fut4, anticorps FUT4
- Sujet
- CD15 is 3-fucosyl-N-acetyllactosamine (3-FAL) also known as Lewis X, 3-FAL, X-hapten, and SSEA-1. CD15 is expressed on granulocytes and monocytes. It has also been shown to be expressed on Langerhans cells and some malignant cells. CD15 has been implicated in adhesion as well as chemotaxis, phagocytosis, and bactericidal activity.
-